Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Galmed Pharmaceuticals Ltd. (GLMD) had Current Assets of $11.71M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-2.72M |
|
-- |
|
-- |
|
$2.77M |
|
$-2.77M |
|
$0.05M |
|
$-2.72M |
|
$-2.72M |
|
$-2.72M |
|
$-2.72M |
|
$-2.72M |
|
$-2.72M |
|
$-2.77M |
|
$-2.79M |
|
0.95M |
|
0.95M |
|
$-2.86 |
|
$-2.86 |
|
| Balance Sheet Financials | |
|
Current Assets |
$11.71M |
$0.05M |
|
$6.57M |
|
$18.28M |
|
$2.81M |
|
-- |
|
$2.73M |
|
$5.54M |
|
$12.74M |
|
$6.33M |
|
$12.74M |
|
1.00M |
|
| Cash Flow Statement Financials | |
$-4.66M |
|
$2.40M |
|
$1.20M |
|
$4.11M |
|
$3.04M |
|
$-1.06M |
|
$0.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.38% |
|
-43.00% |
|
-14.89% |
|
-21.38% |
|
$12.73 |
|
$-4.90 |
|
$-4.90 |
|